Taysha Gene Therapies (TSHA)

Taysha Gene Therapies (TSHA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• TSHA last traded at $4.33, 5.87% on the day.
• Taysha Gene Therapies: market cap $1.41B, P/E -10.2, revenue $11.79M over the last four quarters.
• Over the past year TSHA returned 7.44%; year to date -21.27%.

Updated 2026-11-07 11:50 UTC